UCLA Journal of Radiation Oncology FALL 2024 and ANNUAL REPORT - Flipbook - Page 21
UCLA RADIATION ONCOLOGY JOURNAL
IMPACT
The findings highlight a promising shift in prostate cancer treatment practices, highlighting
the potential of MRI-guided radiation therapy to improve patient outcomes.
“This study adds strong evidence that the enhanced precision and accuracy afforded by
MRI-guided SBRT leads to significantly fewer urinary, bowel, and sexual side effects for men
receiving prostate SBRT,” noted Dr. Amar Kishan(Link opens in new window), executive vice
chair of radiation oncology at the David Geffen School of Medicine at UCLA and first author
of the study. “The MRI-guided approach, which includes real-time tracking of the prostate
itself and the use of a built-in MRI to help deliver the radiation, allows us to use significantly
narrower planning margins when delivering radiation, leading to less radiation to normal
tissues. This in turn reduces the risk of enduring side effects that can impact a patient’s quality
of life.”
JOURNAL
The study was published in the journal European Urology and presented earlier this year at
the American Society for Radiation Oncology (ASTRO) meeting in Washington D.C.
AUTHORS
Other UCLA authors are James Lamb, Holly Wilhalme, Maria Casado, Natalie Chong, Lily
Zello, Jesus Juarez, Tommy Jiang, Beth Neilsen, Daniel Low, Yingli Yang, John Neylon, Vincent
Basehart, Luca Valle and Minsong Cao.
Contributed by: Denise Heady
Denise Heady is a science communications and media relations
manager at UCLA Health. She covers the clinical cancer program
along with basic and clinical translational research for the UCLA
Health Jonsson Comprehensive Cancer Center.
21
